The best stocks under $30 to buy today depend on today’s chart. The fact is, 99.9% of these cheap stocks will eventually be worth less than they are right now. That’s why I tell my students to build a watchlist every day.
The best traders watch more stocks than they trade. That’s essential for getting to know the charts of these stocks — these charts will give you valuable info about their future moves. If you study the patterns these stocks follow, you can find opportunities for the kind of small gains that can grow a small account fast.
Today I’ll show you how to build a watchlist for stocks under $30. Read on for the results!
Table of Contents
What Are the Best Stocks to Buy Under $30 in July 2024?
To find the best stocks to buy under $30 in July 2024 requires a top-level stock screener. I use the one in StocksToTrade — I helped design it, so it has all the tools and customizations I look for to create my stock watchlists.
Try StocksToTrade for 14 days and see how it helps your watchlist skills — only $7!
To find watch-worthy stocks under $30, I input the following criteria:
- Last Price ≤ $30
- Last Price ≥ $10
- Volume ≥ 50,000
When I run this screen in July 2024 and sort by percent change, it gives me the following top results:
Best Stocks Under $30 to Buy in July 2024
The best stocks under $30 in July 2024 are:
- Novavax Inc. [NASDAQ: NVAX]
- Cabaletta Bio Inc. [NASDAQ: CABA]
- ACM Research Inc. [NASDAQ: ACMR]
- Vir Biotechnology Inc. [NASDAQ: VIR]
- Aehr Test Systems [NASDAQ: AEHR]
This is a watchlist — not a “buy list.”
I’m sharing this so you can see my process. If you want to see more NO-COST watchlists, you can sign up for my weekly watchlist here.
Read on for the best stocks that I’m watching today!
Novavax Inc. [NASDAQ: NVAX]
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
Cabaletta Bio Inc. [NASDAQ: CABA]
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers.
ACM Research Inc. [NASDAQ: ACMR]
ACM Research Inc is a U.S.-based company. It is engaged in developing, manufacturing, and selling single-wafer wet cleaning equipment, which is used by semiconductor manufacturers in numerous manufacturing steps to remove particles, contaminants, and other random defects to improve product yield, in fabricating integrated circuits, or chips. The company offers space alternated phase shift which employs alternating phases of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces on a microscopic level; and Timely Energized Bubble Oscillation technology which provides effective, damage-free cleaning for both conventional two and three-dimensional patterned wafers at process nodes.
Vir Biotechnology Inc. [NASDAQ: VIR]
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company’s pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.
Aehr Test Systems [NASDAQ: AEHR]
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for the company’s products in package, wafer level, and singulated die/module level test. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
Which Is the Cheapest High-Potential Stock to Buy Right Now?
To find the cheapest high-potential stocks, you have to study their charts.
Take a look at the 1-year chart for Clean Vision Corp. [OTCPK: CLNV]:
See how many 100% spikes this stock had in the past year? Each one of these spikes was a trading opportunity — that’s the way I’ve made over $8,000 in total earnings trading this stock (click the link to see my individual trades).
However, that’s not a recommendation to “buy” this stock. See how it drops after every spike?
CLNV follows my 7-step pennystocking framework perfectly. This framework isn’t just for penny stocks though… You can also see its patterns play out in higher priced stocks like Tesla Inc. (NASDAQ: TSLA).
This is the chart you have to commit to memory:
Remember this chart well, its the basis for my 7-step framework, @30DayBoot & @completepenny & you must study not to fall prey to greed/ignorance or you'll get wrecked like 90% of traders. It's VITAL to sell into excessive strength/hype, do not just hold & hope like most newbies pic.twitter.com/QsAGHsI6lp
— Timothy Sykes (@timothysykes) February 28, 2021
What Are the Stocks Under $30 with the Highest Potential?
Look up at the charts of the stocks above. Do you see any spikes in their long-term chart?